The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 24, 2015
Filed:
Dec. 06, 2012
Transtech Pharma, Llc, High Point, NC (US);
Adnan M. M. Mjalli, Oak Ridge, NC (US);
Christopher Behme, Jamestown, NC (US);
Daniel P. Christen, Jamestown, NC (US);
Devi Reddy Gohimukkula, Jamestown, NC (US);
Dharma Rao Polisetti, High Point, NC (US);
James C. Quada, Jr., High Point, NC (US);
Jennifer L. R. Freeman, Winston-Salem, NC (US);
Kalpathy Santhosh, Jamestown, NC (US);
Muralidhar Bondlela, Greensboro, NC (US);
Mustafa Guzel, Jamestown, NC (US);
Ravindra Reddy Yarragunta, Greensboro, NC (US);
Robert Carl Andrews, Jamestown, NC (US);
Stephen Thomas Davis, Durham, NC (US);
Thomas Scott Yokum, Greensboro, NC (US);
TransTech Pharma, LLC, High Point, NC (US);
Abstract
The present invention is directed to substituted azoanthracene derivatives or pharmaceutically acceptable salts thereof that modulate the human GLP-1 receptor and that may be useful in the treatment of diseases, disorders, or conditions in which modulation of the human GLP-1 receptor is beneficial, such as diabetes mellitus type 2. The invention is also directed to pharmaceutical compositions comprising these compounds and to the use of these compounds and compositions in the treatment of such diseases, disorders, or conditions in which modulation of the human GLP-1 receptor is beneficial.